How Is Rising Cancer Prevalence Helping Protein A Resin Market Growth?

By Author: Pramod Kumar
Total Articles: 97
Comment this article

Cancer kills over 9.5 million people each year, as per the World Health Organization (WHO), which makes it the second leading cause of human mortality. With the increasing prevalence of this disease in developed as well as developing countries, the pressure on the medical fraternity to find an effective treatment is increasing. Though there are numerous therapies available, such as surgery, radiation, chemotherapy, and targeted medication, cancer has a high chance of coming back. This is why extensive research is being put in by pharmaceutical and biotechnology companies.

Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/report-sample

These therapies are not just used for the treatment of cancer, but for a number of other chronic diseases, such as multiple sclerosis (MS), rheumatoid arthritis (RA), cardiovascular diseases (CVD), ulcerative colitis, Crohn’s disease, psoriasis, anemia, and hemophilia, and several infectious diseases. Because of all such uses of these biopharmaceuticals, the geriatric population could generate a significantly high demand for ...
... them. As people age, they become susceptible to these and many more health issues, on account of their immunological and physical weakness. With the number of people in the age group of 65 and above set to cross 1.5 billion by 2050, as per the United Nations, the demand for proteins and mAbs would rise too.

Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=protein-a-resin-market

Of the two main application of this product discussed above, antibody purification has accounted for its wider consumption, simply because mAbs are being used as therapy for a large number diseases. This is also why, among all the sectors which use protein A resin, viz. academic institutes and research laboratories and biotechnology and pharmaceutical industries, the latter use them more, to produce antibodies. Moreover, the use of this biological compound in research is also significant, especially with government agencies, such as the National Institutes of Health, heavily funding medical and life sciences research.

Pramod has around 7 years of experience in market research and consulting services for healthcare industry. He holds varied experience in market sizing and forecasting with varied models, competition landscape, consumer behavior analysis, opportunity analysis, product/company benchmarking, data mining and others. He has successfully delivered multiple projects on go-to-market strategies, pricing strategy, price point analysis, Business Expansion, market entry and exit, share analysis and others. Prior to joining P&S Intelligence, he worked with different research companies, including Transparency Market Research and MarketsandMarkets Pvt Ltd. Some of the projects delivered by him include Scar Treatment Market, Skin Replacement and Substitutes Market, and Energy-Based Aesthetic Devices Market.